CITÓMICA
HudsonAlpha Institute for Biotechnology
Huntsville, Estados UnidosPublicacións en colaboración con investigadores/as de HudsonAlpha Institute for Biotechnology (7)
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2016
-
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis
Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602
-
Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1384-1391
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Identification of risk loci for crohn's disease phenotypes using a genome-wide association study
Gastroenterology, Vol. 148, Núm. 4, pp. 794-805
2013
-
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300
Gut, Vol. 62, Núm. 10, pp. 1440-1445
2012
-
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes
Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557